Medtech M&A activity waned in June - twelve acquisitions were announced and closed during the month, a dip in activity compared to the 21 deals recorded in the same period last year, and the 17 recorded in May.
In the biggest deal of the month, Johnson & Johnson accepted $2.1bn for its LifeScan Inc. business from private equity firm Platinum Equity. J&J announced in March the...